Skip to content

Clinical study of Zhenwu Decoction combined with enhanced external counterpulsation in treating chronic heart failure with heart-kidney Yang deficiency type

Clinical study of Zhenwu Decoction combined with enhanced external counterpulsation in treating chronic heart failure with heart-kidney Yang deficiency type

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2024000411
Enrollment
Unknown
Registered
2024-09-11
Start date
2024-10-01
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic heart failure

Interventions

Zhenwu Tang Group:Oral drugs are based on ARB preparations aldosterone antagonists and beta-blockers with EECP treatment and Zhenwu Decoction
Control group:Oral drugs are based on ARB preparations aldosterone antagonists and beta-blockers with EECP treatment

Sponsors

Shibei Hospital of Shanghai
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Diagnostic criteria of Western medicine: a history of coronary heart disease in the past while meeting the above diagnostic criteria for chronic heart failure. 2. TCM diagnostic criteria: According to the relevant content of Shanghai TCM Diagnosis and Treatment Routine (second edition) the main symptoms are: palpitation shortness of breath asthma feeling afraid of cold hands and feet not warm. Secondary symptoms: oliguria edema abdominal distension and loose stool pale gray. Tongue and pulse: the tongue is light and fat or has tooth marks and the pulse is heavy or late. The main disease must have 2 items the secondary disease has 2 items combined with the tongue and pulse the diagnosis can be established. 3. Age: 45 ~ 85 years old. 4. Grading of heart function: According to the New York Heart Association (NYHA) grading of heart function the heart function is grade II to III.

Exclusion criteria

Exclusion criteria: 1. Patients with bronchial asthma chronic bronchitis pulmonary heart disease and chronic obstructive pulmonary disease. 2. Patients with unstable blood pressure control. 3. Patients with acute cardiac insufficiency. 4. Severe liver and kidney dysfunction and heart failure due to kidney liver and other important organ failure. 5. Patients with serious primary diseases such as endocrine system and hematopoietic system.(YNMT)·

Design outcomes

Primary

MeasureTime frame
5/5000 echocardiography;PRO-BNP;

Countries

CHINA

Contacts

Public ContactJin SHU

Shibei Hospital of Shanghai

shu_jin@126.com18918255966

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026